Blackberries Getting Blacked Out, Imitate Amateur Base Jumpers Sans Parachute!
As competition that is as inevitable as gravity itself both validates our contrarian thesis and causes Research in Motion’s stock to imitate amateur base jumpers, sans parachute…
From CNBC: RIM Shares Plunge After Firm Lowers Guidance
Research In Motion shares were hammered in after-hours trading Thursday after the BlackBerry maker lowered its earnings and revenue guidance for the first quarter. Shares resumed trading at 4:30 pm ET after being halted for more than 20 minutes. Get after-hour quotes for Research in Motion here.
The company said it expects first-quarter earnings of between $1.30 to $1.37 a share short of analyst expectations of $1.48 a share.
Also, RIM said it sees first quarter revenue slightly below its previous guidance of between $5.2 and $5.6 billion.
RIM blamed the move to weak shipments of its BlackBerry phones and a shift toward handsets with lower price points. The firm has been struggling to compete against Apple’s popular iPhone and other rivals of the smartphone market.
From Bloomberg: RIM Plunges as Analysts See Lost Credibility With Forecast Cut
Research In Motion Ltd. (RIMM) plunged in late trading yesterday as analysts said a r duced profit forecast hurts management’s credibility and raises pressure on the company as it heads into an annual trade show next week… “This further damages already low credibility, making them the ‘poster boy’ for a show-me story from here,” Mike Abramsky, an analyst at RBC Capital Markets in Toronto who has a “top pick” rating on the company, said in a research note. “Management needs to deliver on the product side,” said Taylor, who manages about $14.5 billion including RIM and Apple shares. “That includes competitive next-generation smartphones and building out the app library.” Apple offers more than 350,000 software applications, or apps, and Google’s Android Market has more than 150,000, compared with more than 25,000 in BlackBerry App World. RIM fell $6.17, or 11 percent, to $50.43 in late trading yesterday, after closing at $56.59 on the Nasdaq Stock Market. It has lost 2.7 percent this year as of yesterday’s close.
‘Aging’ BlackBerrys
Co-Chief Executive Officer Jim Balsillie told analysts on a conference call yesterday that he wished the new products would come sooner to replace current BlackBerry devices. “The issue is an aging that happens in your higher-end products and it affects margin,” said Balsillie. “All things being equal we would love to have these products earlier and not be having this call. Because it’s such a big upgrade, it takes longer.” In updating its forecast, RIM said BlackBerry shipments will be at the lower end of the range of 13.5 million to 14.5 million it projected last month, and the mix of devices will shift toward cheaper models. Sales in the quarter ending May 28 will be “slightly below” the $5.2 billion to $5.6 billion the company had forecast. Analysts had predicted earnings of $1.50 a share on sales of $5.44 billion, the average estimates compiled by Bloomberg.
‘Off a Cliff’
“The sales on their existing devices must have fallen off a cliff,” said Matt Thornton, an Avian Securities LLC analyst in Boston who has a “neutral” rating on the stock. “They are getting hit by a combination of a stale portfolio and heated competition on devices.” RIM said shipments of its PlayBook tablet computer, which started selling in the U.S. April 19 to challenge Apple’s iPad, are in line with its previous estimates.
The Playbook pales in comparison to the competition. The iPad 2 pwns it! Asus has come out with an Android Honeycomb tablet that literally enables you to do REAL work with 16 hours of battery life and a realistic keyboard. . Samsung has come out with a tablet under 9 mm thick, thinner, lighter and faster than the iPad. LG is pushing glasses free 3D tables. And then there are about 200 other competitors. RIM is lost!
Sliding Share
RIM’s share of worldwide smartphone sales slipped to 14 percent in the fourth quarter from 20 percent a year earlier, according to Canalys, a British research company. Apple’s share was unchanged at 16 percent, while Android’s more than tripled to 33 percent. The forecast shows that higher-end BlackBerrys like the Torch, designed to compete with the iPhone and Android devices, are missing estimates, said Michael Walkley, an analyst at Canaccord Genuity Ltd.
“Higher-end phones have not sold so well,” said Walkley, who has a “hold” rating on the stock. “The investment community was already skeptical about the full-year guidance of $7.50 and this gives them reason to be more skeptical.”
Now, let’s do this by the numbers – reverse chronology to be exact…
Research in Motion Drops 10% After Hours, Precisely As We Warned Two Months Ago – MARGIN COMPRESSION!!! Thursday, March 24th, 2011
Blackberries Lost More Market Share Than We Bearishly Anticipated While RIMM’s Share Price Spikes: Is It Time To Revisit the Bear Thesis? Thursday, January 20th, 2011
And from the valuation section of our Forensic Report (those who have downloaded it can refer to page 30)…
As you can see, we did a phenomenal job at anticipating the share price fall and the practical floor. Those of you who used options and/or leverage with proper risk management should have benefited handsomely. Of course, this particularly industry segment moves much more rapidly than most, which is why we have taken the opportunity to add flexibility in our valuations and analysis (page 32)…
As is usual, I welcome any and all to compare BoomBustBlog research to anything available from the sell side. I am confident many will wish to subscribe after an apples to apples comparison. This report release to the public is done in anticipation of the much more comprehensive, 65 page Google Forensic Valuation (hopefully by later on today or tomorrow morning) and the upcoming Apple Forensic Valuation. Please keep in mind that the Research in Motion story is not over, by a long shot. It looks as if they may have pulled a much needed rabbit out of their hat with their new tablet, but at this point it is still vaporware from our perspective since I have yet to get my hands on one. If it is what it is chocked up to be, it will then be up to management to execute. Their track record over their last 3 attempts at larger screen form factors have been wanting, at best, but maybe the fourth time around is a charm.
Professional subscribers should take advantage of the interactive valuation tools that I have made available to adjust the assumptions in the valuation model to keep abreast of the RIM situation (see RIMM Multivariate Valuation Model). We have not updated the assumptions since before the earnings announcement, so there is some fine tuning to be done regarding the valuation report, but the gist of the story remains the same, and the report’s premise remains quite valid. I recommend all paying subscribers use the market share tools to assist in fine tuning their assumptions moving forward. This is a rapidly changing landscape, and what was once the underdog may become the champion – seemingly overnight. I, personally, am still quite skeptical of RIM management’s ability to execute in this environment, but I am keeping my eyes open.
- RIMM Forensic Analysis and Valuation – Professional & Institutional: Formerly available to Pro and institutional subscribers, now released to the public. You will have to register for a free subscription to the site to download.
- RIMM Multivariate Valuation Model – Pro subscribers
- Smartphone Market Model – Blog Download Version – all paying subscribers
- Mobile Operating System Market Share Model – all paying subscribers
Previous Research in Motion commentary
Quick Thought On How Research in Motion Can Maintain Their Market Share and Take Even MoreTuesday, September 21st, 2010
A Quick Review of Research in Motion’s Q2 2011 Earnings Announcement Monday, September 20th, 2010
- The Blacker the Berry, the Smaller the Market Share?
- Despite What May Appear to Be Strong Fundamentals RIMM Is In Trouble, Look Past the Present and Into the Future
- BoomBustBlog Research Opinion Hits the Mainstream Media, Sort Of…
- As I Have Anticipated, There is Absolutely No Fire in the Torch, Except for the One That’s Frying RIMM’s Share Price
- After Getting a Glimpse of the New Windows Phone 7 Functionality, RIMM is Looking More Like a Short Play
- RIM Smart Phone Market Share, RIP?
- This Quarter Offers a Lot of Challenges for Smart Phone Vendors with Fruit in Their Names!
- Many More Black Eyes for the Blackberry? A Complete Forensic Analysis of Research in Motion
- The BoomBustBlog Multivariate Research in Motion Valuation Model: Ready for Download
- As Research in Motion Continues Its Inevitable Downward Descent In Both Equity Value and Market Share, Investors Should Tweak Their Assumptions Accordingly
Subscription content (click here to subscribe):
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Lion’s Mane Mushroom
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes:
Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.
Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.
Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.
Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.
Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules. Today Be 100% Satisfied Or Receive A Full Money Back Guarantee Order Yours Today By Following This Link.